Corey E - Search Results

1

Response to supraphysiological testosterone is predicted by a distinct androgen receptor cistrome.

Qiu X, Brown LG, Conner JL, Nguyen HM, Boufaied N, Abou Alaiwi S, Seo JH, El Zarif T, Bell C, O'Connor E, Hanratty B, Pomerantz M, Freedman ML, Brown M, Haffner MC, Nelson PS, Feng FY, Labbé DP, Long HW, Corey E. Qiu X, et al. Among authors: corey e. JCI Insight. 2022 May 23;7(10):e157164. doi: 10.1172/jci.insight.157164. JCI Insight. 2022. PMID: 35603787 Free PMC article.

2

Identification of differentially expressed prostate genes: increased expression of transcription factor ETS-2 in prostate cancer.

Liu AY, Corey E, Vessella RL, Lange PH, True LD, Huang GM, Nelson PS, Hood L. Liu AY, et al. Among authors: corey e. Prostate. 1997 Feb 15;30(3):145-53. doi: 10.1002/(sici)1097-0045(19970215)30:3<145::aid-pros1>3.0.co;2-l. Prostate. 1997. PMID: 9122038

3

LNCaP produces both putative zymogen and inactive, free form of prostate-specific antigen.

Corey E, Brown LG, Corey MJ, Buhler KR, Vessella RL. Corey E, et al. Among authors: corey mj. Prostate. 1998 May;35(2):135-43. doi: 10.1002/(sici)1097-0045(19980501)35:2<135::aid-pros7>3.0.co;2-i. Prostate. 1998. PMID: 9568677

4

Inhibition of androgen-independent growth of prostate cancer xenografts by 17beta-estradiol.

Corey E, Quinn JE, Emond MJ, Buhler KR, Brown LG, Vessella RL. Corey E, et al. Clin Cancer Res. 2002 Apr;8(4):1003-7. Clin Cancer Res. 2002. PMID: 11948106

5

Establishment and characterization of osseous prostate cancer models: intra-tibial injection of human prostate cancer cells.

Corey E, Quinn JE, Bladou F, Brown LG, Roudier MP, Brown JM, Buhler KR, Vessella RL. Corey E, et al. Prostate. 2002 Jun 1;52(1):20-33. doi: 10.1002/pros.10091. Prostate. 2002. PMID: 11992617

6

Zoledronic acid exhibits inhibitory effects on osteoblastic and osteolytic metastases of prostate cancer.

Corey E, Brown LG, Quinn JE, Poot M, Roudier MP, Higano CS, Vessella RL. Corey E, et al. Clin Cancer Res. 2003 Jan;9(1):295-306. Clin Cancer Res. 2003. PMID: 12538482

7

LuCaP 35: a new model of prostate cancer progression to androgen independence.

Corey E, Quinn JE, Buhler KR, Nelson PS, Macoska JA, True LD, Vessella RL. Corey E, et al. Prostate. 2003 Jun 1;55(4):239-46. doi: 10.1002/pros.10198. Prostate. 2003. PMID: 12712403

8

Prostate cancer expression of runt-domain transcription factor Runx2, a key regulator of osteoblast differentiation and function.

Brubaker KD, Vessella RL, Brown LG, Corey E. Brubaker KD, et al. Among authors: corey e. Prostate. 2003 Jun 15;56(1):13-22. doi: 10.1002/pros.10233. Prostate. 2003. PMID: 12746842

9

Bone morphogenetic protein signaling in prostate cancer cell lines.

Brubaker KD, Corey E, Brown LG, Vessella RL. Brubaker KD, et al. Among authors: corey e. J Cell Biochem. 2004 Jan 1;91(1):151-60. doi: 10.1002/jcb.10679. J Cell Biochem. 2004. PMID: 14689587

10

Metastases of prostate cancer express estrogen receptor-beta.

Lai JS, Brown LG, True LD, Hawley SJ, Etzioni RB, Higano CS, Ho SM, Vessella RL, Corey E. Lai JS, et al. Among authors: corey e. Urology. 2004 Oct;64(4):814-20. doi: 10.1016/j.urology.2004.05.036. Urology. 2004. PMID: 15491740

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

640 results

Search Page